Factor Xa inhibitors: all 607 studies that test it
Page 7 of 7. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- BMS-562247 in Subjects Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00097357Phase 2/3
- SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCompletedNCT00071279Phase 3
- Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)CompletedNCT00070655Phase 3
- Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)CompletedNCT00067093Phase 3
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismCompletedNCT00062803Phase 3
- A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)WithdrawnNCT00060554Phase 2
- A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).CompletedNCT00038961Phase 3